| Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas S Ryall, M Zapotocky, K Fukuoka, L Nobre, AG Stucklin, J Bennett, ... Cancer cell 37 (4), 569-583. e5, 2020 | 294 | 2020 |
| Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas A Lassaletta, M Zapotocky, M Mistry, V Ramaswamy, M Honnorat, ... Journal of Clinical Oncology 35 (25), 2934-2941, 2017 | 291 | 2017 |
| BRAF Mutation and CDKN2A Deletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma M Mistry, N Zhukova, D Merico, P Rakopoulos, R Krishnatry, M Shago, ... Journal of clinical oncology 33 (9), 1015-1022, 2015 | 286 | 2015 |
| The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications A Arcaro, AS Guerreiro Current genomics 8 (5), 271-306, 2007 | 286 | 2007 |
| Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas AS Guerreiro Stucklin, S Ryall, K Fukuoka, M Zapotocky, A Lassaletta, ... Nature Communications 10, 4343, 2019 | 259 | 2019 |
| Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma LK Donovan, A Delaidelli, SK Joseph, K Bielamowicz, K Fousek, ... Nature medicine 26 (5), 720-731, 2020 | 161 | 2020 |
| Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas ASG Stucklin, S Ryall, K Fukuoka, M Zapotocky, A Lassaletta, C Li, ... Nature communications 10, 2019 | 152 | 2019 |
| Clinical and treatment factors determining long‐term outcomes for adult survivors of childhood low‐grade glioma: a population‐based study R Krishnatry, N Zhukova, AS Guerreiro Stucklin, JD Pole, M Mistry, I Fried, ... Cancer 122 (8), 1261-1269, 2016 | 146 | 2016 |
| A hematogenous route for medulloblastoma leptomeningeal metastases L Garzia, N Kijima, AS Morrissy, P De Antonellis, A Guerreiro-Stucklin, ... Cell 172 (5), 1050-1062. e14, 2018 | 124 | 2018 |
| A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance AS Guerreiro, S Fattet, DW Kulesza, A Atamer, AN Elsing, T Shalaby, ... Molecular Cancer Research 9 (7), 925-935, 2011 | 112 | 2011 |
| Targeting the PI3K p110α isoform inhibits medulloblastoma proliferation, chemoresistance, and migration AS Guerreiro, S Fattet, B Fischer, T Shalaby, SP Jackson, ... Clinical Cancer Research 14 (21), 6761-6769, 2008 | 100 | 2008 |
| EANO–EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma E Franceschi, S Hofer, AA Brandes, D Frappaz, RD Kortmann, ... The Lancet Oncology 20 (12), e715-e728, 2019 | 72 | 2019 |
| Profound clinical and radiological response to BRAF inhibition in a 2‐month‐old diencephalic child with hypothalamic/chiasmatic glioma A Lassaletta, A Guerreiro Stucklin, V Ramaswamy, M Zapotocky, ... Pediatric Blood & Cancer 63 (11), 2038-2041, 2016 | 70 | 2016 |
| The transcriptional landscape of Shh medulloblastoma P Skowron, H Farooq, FMG Cavalli, AS Morrissy, M Ly, LD Hendrikse, ... Nature communications 12 (1), 1749, 2021 | 61 | 2021 |
| Novel role for insulin as an autocrine growth factor for malignant brain tumour cells A Arcaro, KT Doepfner, D Boller, AS Guerreiro, T Shalaby, SP Jackson, ... Biochemical Journal 406 (1), 57-66, 2007 | 60 | 2007 |
| Review of molecular classification and treatment implications of pediatric brain tumors ASG Stucklin, V Ramaswamy, C Daniels, MD Taylor Current opinion in pediatrics 30 (1), 3-9, 2018 | 52 | 2018 |
| Multiplex detection of pediatric low-grade glioma signature fusion transcripts and duplications using the NanoString nCounter system S Ryall, A Arnoldo, R Krishnatry, M Mistry, K Khor, J Sheth, C Ling, ... Journal of Neuropatholgy & Experimental Neurology 76 (7), 562-570, 2017 | 44 | 2017 |
| IGF-IR: potential role in antitumor agents. AS Guerreiro, D Boller, KT Doepfner, A Arcaro Drug news & perspectives 19 (5), 261-272, 2006 | 42 | 2006 |
| Pediatric hemispheric high-grade glioma: targeting the future C Coleman, S Stoller, M Grotzer, AG Stucklin, J Nazarian, S Mueller Cancer and Metastasis Reviews 39, 245-260, 2020 | 35 | 2020 |
| TGF-β Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma KS Kumar, A Neve, ASG Stucklin, CM Kuzan-Fischer, EJ Rushing, ... Cell reports 23 (13), 3798-3812. e8, 2018 | 35 | 2018 |
Michael GrotzerProfessor of Pediatrics, University Children's Hospital of ZurichVerified email at kispi.uzh.ch
